NeoGenomics, Inc. (NEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

SA Transcripts 162.21K Followers Follow NeoGenomics, Inc. ( NEO ) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 7:45 AM EDT Company Participants Anthony Zook - CEO & Director Warren Stone - President & COO Abhishek Jain - Executive VP & CFO Presentation Unknown Analyst Yes. All right. Thank you, everyone, for joining us. My pleasure to introduce the NeoGenomics team. We're glad to have you here at the Morgan Stanley Healthcare Conference this morning. Joined by Anthony Zook, Chief Executive Officer; Warren Stone, President and Chief Operating Officer; and Abhishek Jain, the Chief Financial Officer. So, thank you all for being here. Anthony Zook CEO & Director Thanks for having me. Question-and-Answer Session Unknown Analyst Great. Maybe for Tony, for an investor that is not necessarily incredibly familiar with the NeoGenomics story, what is the simplest way to understand what you all do, how you fit into the precision oncology market, and now that you've been in the seat for a while, what do you think is the biggest misconception that you hear or that you encounter with investors when it comes to your company? Anthony Zook CEO & Director Sure. I guess first, NeoGenomics, pure play oncology, I think, is an important factor. We remain focused in oncology because we think it allows us to better understand and serve our customers. We focus in the community. And so, we're proud of that fact. We help bring innovation into the community setting. Why? That's where the patients are. Almost 80% of patients do seek treatment in the local community, and so we focus relentlessly on that community provider. Our genesis, while that was in diagnosis, our portfolio has continued to evolve in through therapy selection and MRD. I would say the area that is probably not as well understood, and it is our effort to do